000 | 01750 a2200517 4500 | ||
---|---|---|---|
005 | 20250514003400.0 | ||
264 | 0 | _c20010816 | |
008 | 200108s 0 0 eng d | ||
022 | _a0969-9961 | ||
024 | 7 |
_a10.1006/nbdi.2001.0393 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCallizot, N | |
245 | 0 | 0 |
_aThe frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome. _h[electronic resource] |
260 |
_bNeurobiology of disease _cJun 2001 |
||
300 |
_a447-58 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiparkinson Agents _xpharmacology |
650 | 0 | 4 |
_aApomorphine _xpharmacology |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aCorpus Striatum _xcytology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aElectromyography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenes, Recessive |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aIndoles _xpharmacology |
650 | 0 | 4 |
_aLevodopa _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMemory Disorders _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C3H |
650 | 0 | 4 | _aMice, Neurologic Mutants |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNeurons _xenzymology |
650 | 0 | 4 |
_aParkinson Disease, Secondary _xdrug therapy |
650 | 0 | 4 |
_aPostural Balance _xdrug effects |
650 | 0 | 4 |
_aSelegiline _xpharmacology |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xanalysis |
700 | 1 | _aGuénet, J L | |
700 | 1 | _aBaillet, C | |
700 | 1 | _aWarter, J M | |
700 | 1 | _aPoindron, P | |
773 | 0 |
_tNeurobiology of disease _gvol. 8 _gno. 3 _gp. 447-58 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/nbdi.2001.0393 _zAvailable from publisher's website |
999 |
_c11371194 _d11371194 |